In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets
about
Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantationNK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell EngraftmentIdentification and characterization of the specific murine NK cell subset supporting graft-versus-leukemia- and reducing graft-versus-host-effects.Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantationIndoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethalitySequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantationThe cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host diseaseAdenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation.Kinetics of IFN-γ and IL-17 Production by CD4 and CD8 T Cells during Acute Graft-versus-Host Disease.Depletion of host CCR7(+) dendritic cells prevented donor T cell tissue tropism in anti-CD3-conditioned recipients.Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury.In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host diseaseAltered T-cell entry and egress in the absence of Coronin 1A attenuates murine acute graft versus host disease.NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects.Tissue-specific homing and expansion of donor NK cells in allogeneic bone marrow transplantation.Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantationSeparation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cellsPathogenesis and management of graft-versus-host disease.Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.Shift of graft-versus-host-disease target organ tropism by dietary vitamin A.Nuclear factor-kappaB inducing kinase is required for graft-versus-host disease.Expansion and activation kinetics of immune cells during early phase of GVHD in mouse model based on chemotherapy conditioning.Non-invasive imaging provides spatiotemporal information on disease progression and response to therapy in a murine model of multiple myeloma.Altered effector CD4+ T cell function in IL-21R-/- CD4+ T cell-mediated graft-versus-host diseaseAllogeneic effector/memory Th-1 cells impair FoxP3+ regulatory T lymphocytes and synergize with chaperone-rich cell lysate vaccine to treat leukemia.Blockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host diseaseSequential activation of inflammatory signaling pathways during graft-versus-host disease (GVHD): early role for STAT1 and STAT3.CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHDA diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model.Inflammatory manifestations of experimental lymphatic insufficiencyCCR7 expressing mesenchymal stem cells potently inhibit graft-versus-host disease by spoiling the fourth supplemental Billingham's tenetB7H1/CD80 interaction augments PD-1-dependent T cell apoptosis and ameliorates graft-versus-host diseasePretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantationHuman mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation.Tumor necrosis factor induces tumor promoting and anti-tumoral effects on pancreatic cancer via TNFR1.Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity.Non-invasive bioluminescence imaging to monitor the immunological control of a plasmablastic lymphoma-like B cell neoplasia after hematopoietic cell transplantation.Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantationA novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy.Thiol/redox metabolomic profiling implicates GSH dysregulation in early experimental graft versus host disease (GVHD).
P2860
Q21132345-E5C6A996-A8DC-4403-8123-9F91BE2962C4Q26765845-0751E5FB-658E-4287-851A-5C5693E1D251Q27301956-1432E36E-2C90-4697-BB56-E8946BB55572Q27334243-E402AA5E-A405-4EE8-B189-F293F700C982Q28509235-EA24DDFE-D826-4AAC-9F7F-AB35EBC82A23Q33554385-DC5B1CCD-7415-4883-A31A-DA5E99F4D6F3Q33559627-DC67CDE2-B7B6-46C9-93E7-F0114927C363Q33615249-1C2EB882-2031-4838-99A3-9D0F9BC39D19Q33619021-F3D36740-68DE-451C-8D1E-0CC2E6C7579EQ33756801-0639C0E1-F620-4151-86E6-CF5809D55D7AQ33777543-20B2AD52-BA63-4073-A7CF-ACA872B86C75Q33798249-391A114D-57A4-46FF-A0BD-453B96757946Q33851696-6A7B6FEC-B27B-4D0A-86F1-E11D831A2C14Q33887452-869E1171-50E8-4429-ADB9-0144E999CA81Q33893091-6A502301-9C82-4B30-9212-64752C993890Q33898020-7317A093-99D0-4460-9E8F-EE062B22A723Q33931876-45B63136-2299-46FD-8AC0-E068D0B2920BQ34077479-0864968B-EC82-4FBF-AFBC-CEFDCC889CE4Q34156279-4DD51606-B019-4E18-A020-1827E355C1D6Q34292981-F8A01F19-9B63-429B-9096-E68A02C6413BQ34371137-B53C7BDF-570C-41CC-8BEF-2E9E0DE22BACQ34443622-63E037D7-3D7F-4F60-A03D-C4CD7E81D104Q34540657-F2AE69A3-9315-41D5-967B-8AFF7CB6D1B9Q34643444-462810BD-8102-4035-A6A6-6D6B42715B8BQ34667551-F14B8B0F-237B-4613-B516-8024FE4B5A52Q34667586-4A2466BE-CF9E-46DB-8E8D-66BBAF9D5E4EQ34703720-9215E9D5-9650-4C48-8D44-61E981C3A7AEQ34707286-F47AA5D8-1B30-4CCA-9B74-1695A25CA20CQ34732865-C5A944BE-30D6-4517-A422-7AB836325D2BQ34770407-89F764EC-16F3-4D6F-A455-EAEB2198611BQ34790016-A73A9C31-B089-4BC7-B9D5-F2191E77E2FDQ34810629-3E7ACE1F-490E-4A10-933A-00AECAF904A4Q34973719-22B0072A-6B54-4E85-81C1-5D8D2C79CC89Q35007600-E6A820B5-86F3-4B8A-9EF5-DC564F79A949Q35010079-2DF6E363-5A33-4658-976A-C9902C7105E3Q35037993-A4A700C9-CFC9-44AA-A4B2-D1CBE97F583DQ35069537-3AF8E45D-6375-4F11-8B22-662C1B9170FDQ35085385-8593124E-EB5B-46E4-9EBA-00900FC15157Q35088412-A7242303-D9E1-4115-8CEA-7DBB3942D3ECQ35099719-7459FC52-4C40-447F-852F-ADD67F01F2D0
P2860
In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
In vivo analyses of early even ...... infiltration of T-cell subsets
@ast
In vivo analyses of early even ...... infiltration of T-cell subsets
@en
type
label
In vivo analyses of early even ...... infiltration of T-cell subsets
@ast
In vivo analyses of early even ...... infiltration of T-cell subsets
@en
prefLabel
In vivo analyses of early even ...... infiltration of T-cell subsets
@ast
In vivo analyses of early even ...... infiltration of T-cell subsets
@en
P2093
P2860
P1433
P1476
In vivo analyses of early even ...... infiltration of T-cell subsets
@en
P2093
Andreas Beilhack
Courtney B Wieland
Edward I Herman
Enosh M Baker
Georg F Beilhack
Jeanette Baker
Robert S Negrin
Stephan Schulz
P2860
P304
P356
10.1182/BLOOD-2005-02-0509
P407
P577
2005-04-26T00:00:00Z